Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy IDEXX Laboratories (IDXX) stocks
Learn how to easily invest in IDEXX Laboratories stocks.
IDEXX Laboratories is a diagnostics & research business based in the US. IDEXX Laboratories stocks (IDXX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $468.94 – an increase of 1.7% over the previous week. IDEXX Laboratories employs 10,780 staff and has a trailing 12-month revenue of around $3.4 billion.
How to buy IDEXX Laboratories stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – IDXX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
National Bank Direct Brokerage
- Commission-free trading
- Several account types available
- Access to array of research tools
CIBC Investor's Edge
- Easy to use platform
- Low fees
- Student and young investor discounts
- Access to international stock exchanges
- Low margin rates
- Powerful research tools
What's in this guide?
- Can I buy shares in IDEXX Laboratories?
- Has coronavirus impacted IDEXX Laboratories shares?
- IDEXX Laboratories shares summary
- Compare share dealing platforms
- Is IDEXX Laboratories stock a buy or sell?
- IDEXX Laboratories performance over time
- Is IDEXX Laboratories suitable for ethical investing?
- Are IDEXX Laboratories shares over-valued?
- IDEXX Laboratories's financials
- How volatile are IDEXX Laboratories shares?
- Does IDEXX Laboratories pay a dividend?
- Have IDEXX Laboratories shares ever split?
- Other common questions
IDEXX Laboratories stock price (NASDAQ:IDXX)Use our graph to track the performance of IDXX stocks over time.
IDEXX Laboratories shares at a glance
|Latest market close||$468.94|
|52-week range||$317.06 - $515.79|
|50-day moving average||$482.93|
|200-day moving average||$428.39|
|Wall St. target price||$559.67|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$8.20|
Buy IDEXX Laboratories stocks from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy IDEXX Laboratories stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
IDEXX Laboratories price performance over time
Historical closes compared with the close of $468.94 from 2023-05-26
|1 week (2023-05-23)||1.70%|
|1 month (2023-04-27)||-3.24%|
|3 months (2023-03-03)||-3.91%|
|6 months (2022-11-28)||17.21%|
|1 year (2022-05-27)||N/A|
|2 years (2021-05-28)||-15.98%|
|3 years (2020-05-29)||51.82%|
|5 years (2018-05-31)||125.22%|
Is IDEXX Laboratories stock undervalued or overvalued?
Valuing IDEXX Laboratories stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of IDEXX Laboratories's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
IDEXX Laboratories's P/E ratio
IDEXX Laboratories's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 57x. In other words, IDEXX Laboratories shares trade at around 57x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
IDEXX Laboratories's PEG ratio
IDEXX Laboratories's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 7.2076. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into IDEXX Laboratories's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
IDEXX Laboratories's EBITDA
IDEXX Laboratories's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1 billion.
The EBITDA is a measure of a IDEXX Laboratories's overall financial performance and is widely used to measure a its profitability.
IDEXX Laboratories financials
|Revenue TTM||$3.4 billion|
|Operating margin TTM||27.13%|
|Gross profit TTM||$2 billion|
|Return on assets TTM||21.54%|
|Return on equity TTM||94.43%|
|Market capitalisation||$38.9 billion|
TTM: trailing 12 months
IDEXX Laboratories's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like IDEXX Laboratories.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
IDEXX Laboratories's total ESG risk score
Total ESG risk: 29.79
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and IDEXX Laboratories's overall score of 29.79 (as at 01/01/2019) is nothing to write home about – landing it in it in the 55th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like IDEXX Laboratories is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
IDEXX Laboratories's environmental score
Environmental score: 9.93/100
IDEXX Laboratories's environmental score of 9.93 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that IDEXX Laboratories is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
IDEXX Laboratories's social score
Social score: 14.44/100
IDEXX Laboratories's social score of 14.44 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that IDEXX Laboratories is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
IDEXX Laboratories's governance score
Governance score: 17.91/100
IDEXX Laboratories's governance score puts it squarely in the 6th percentile of companies rated in the same sector. That could suggest that IDEXX Laboratories is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
IDEXX Laboratories share dividends
We're not expecting IDEXX Laboratories to pay a dividend over the next 12 months.
Have IDEXX Laboratories's shares ever split?
IDEXX Laboratories's shares were split on a 2:1 basis on 16 June 2015. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your IDEXX Laboratories shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for IDEXX Laboratories shares which in turn could have impacted IDEXX Laboratories's share price.
IDEXX Laboratories share price volatility
Over the last 12 months, IDEXX Laboratories's shares have ranged in value from as little as $317.06 up to $515.79. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while IDEXX Laboratories's is 1.1921. This would suggest that IDEXX Laboratories's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
IDEXX Laboratories overview
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; OPTI SARS-CoV-2 RT-PCR test kit for human COVID-19 testing; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups.
Stocks similar to IDEXX Laboratories
IDEXX Laboratories in the news
IDEXX Laboratories (NASDAQ:IDXX) Has A Pretty Healthy Balance Sheet
Investing in IDEXX Laboratories (NASDAQ:IDXX) five years ago would have delivered you a 146% gain
IDEXX Laboratories to Present at Stifel Conference and Announces 2023 Investor Day
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing
How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.Read more…
Best stock app for beginners for 2023
The best stock trading app for beginners is easy to use and offers free trades.Read more…
How to read stock charts
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.Read more…
More guides on Finder
Best bad credit loans in PEI
Compare some of the best bad credit loans in PEI.
Your guide to the features, interest rates and fees to expect when you apply for a short-term loan with Credito.
5 apps like Bree in Canada
Pay for unexpected bills and avoid overdrafts when you sign up for apps like Bree.
Debt Relief Canada (reliefcanada.ca) review
Take a closer look at the debt relief solutions, features and fees of Debt Relief Canada.
Desjardins Online Brokerage (Disnat) review 2023
Learn more about Desjardins Online Brokerage (Disnat) to see if it’s the right broker for you.
Guide to finding the best prepaid card in Canada in May 2023
We show you the best prepaid credit cards in Canada, whether you’re looking for a prepaid card with no fees, cash back rewards, or travel perks, or more.
How to buy Sui (SUI) in Canada
This guide provides step-by-step instructions on how to buy Sui, lists some exchanges where you can get it and provides daily price data on (SUI).
5 apps like Nyble in Canada
Compare apps like Nyble in Canada to access emergency funding.
Your guide to buying and financing a car in Canada with RightRide.
Compare bad credit car loans in BC
Your guide to bad credit car loans in BC and how to find the right financing for your needs.